Pondex

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Pondex

Property Description
Active ingredient Mefenamic Acid
Form Capsule or Tablet (Oral administration)
Pharmacological class Nonsteroidal Anti-inflammatory Drug (NSAID)
Common use Relief of pain, inflammation, and fever
Origin Synthetic (Anthranilic Acid Derivative)

What Type of Medicine is Pondex and Its Active Ingredient?

The medicine Pondex is a pharmaceutical preparation classified as a Nonsteroidal Anti-inflammatory Drug (NSAID), which functions to mitigate pain and inflammation. The sole active ingredient in Pondex is Mefenamic Acid, a single, prescription-only (Rx only) compound that chemically belongs to the anthranilic acid derivatives, also known as the fenamate group, of NSAIDs. This drug class functions through the inhibition of the cyclo-oxygenase enzyme, which is central to the body's inflammatory response. The distinct fenamate classification of Mefenamic Acid is clinically recognized for providing effective acute pain relief compared to some other NSAIDs.


Composition, Origin, and Pharmaceutical Form

Mefenamic Acid is a synthetic compound, manufactured to precise specifications, with the molecular formula C15H15NO2. Pondex is a single-ingredient product designed for oral administration, meaning it must be swallowed to achieve a systemic effect throughout the body. The preparation is consistently supplied in standard dosage forms, specifically as a capsule or a tablet, which consist of the active substance combined with appropriate pharmaceutical excipients to facilitate the drug’s stability and absorption following ingestion.


General Therapeutic Role of Mefenamic Acid

The overall purpose of Mefenamic Acid is to provide relief by interrupting the physiological pathway that generates pain and inflammation. This is achieved through its triple action as an analgesic (relieving pain), an anti-inflammatory agent (reducing swelling and irritation), and an antipyretic (lowering fever). Mefenamic Acid is utilized for its efficacy in providing short-term relief for acute discomfort by targeting inflammatory mediators. By maintaining a Rx-only status, the drug's use is medically controlled, making it a reliable option for conditions like managing temporary pain and elevated body temperature.

Regulatory References

  1. NIH Mefenamic Acid
  2. NIH LiverTox

What side effects are possible with Pondex?

Possible Side Effects and Safety Information

Pondex (Mefenamic Acid) is a Nonsteroidal Anti-inflammatory Drug (NSAID) whose safety profile is officially characterized by potential risks primarily affecting the gastrointestinal and cardiovascular systems, as stipulated in regulatory documents.

Adverse reactions are grouped by the affected system. Common effects documented in official labeling typically include diarrhea, abdominal pain, nausea, vomiting, and headache. If diarrhea is persistent, regulatory documents indicate that discontinuation may be considered.

Serious Adverse Reactions and Safety Warnings

Official labeling includes specific warnings regarding serious, potentially fatal, adverse events. These risks may increase with the duration of use and higher doses.

System-Organ Class Serious Adverse Reaction (Documented)
Cardiovascular Thrombotic Events (e.g., Myocardial Infarction, Stroke)
Gastrointestinal Bleeding, Ulceration, and Perforation
Dermatologic Severe Skin Reactions (e.g., SJS, TEN, DRESS)
Renal Renal Papillary Necrosis and acute renal injury

Population-Specific Safety Notes

Certain patient groups require specific safety considerations noted in the official prescribing information. Older adults face an increased frequency of adverse reactions, particularly serious gastrointestinal bleeding. Use is officially restricted or contraindicated in patients with active gastrointestinal ulceration, severe renal impairment, and during the third trimester of pregnancy (due to fetal risk), as well as for pain management following Coronary Artery Bypass Graft (CABG) surgery.

Overdose and Emergency Response

Overdose and when to seek help — Official Regulatory Information for Pondex

Official government regulatory documents, such as those published by the FDA or EMA, define the critical information regarding drug overdose for patients and healthcare providers. For the substance referenced as Pondex, specific, publicly accessible regulatory prescribing information that outlines a standardized overdose profile is not available or widely recognized.

Documented Overdose Profile

Overdose Component Regulatory Statement
Documented Manifestations Official regulatory sources do not explicitly list the signs and symptoms observed in cases of acute Pondex overdose.
Severity Classification No official classification or severity grading for Pondex overdose is found in government labeling.
Antidote / Management A specific antidote or standardized supportive management protocol for Pondex is not documented in official prescribing information.

When Immediate Medical Help is Required

Since explicit regulatory instructions for Pondex are not defined, general principles for drug safety advise that any suspected overdose must be treated as a medical emergency. If an individual has taken more than the prescribed amount or exhibits unusual symptoms, the following immediate actions are warranted:

  • Seek urgent medical attention immediately by contacting emergency services.
  • Contact a poison control center for guidance.

These actions are critical when the specific clinical course of an overdose is not officially defined, ensuring prompt professional intervention.

Therapeutic Uses of Pondex

What Pondex Treats: Main Uses and Benefits

The medication is commonly used to help manage symptoms related to mild to moderate pain and is relevant in contexts involving menstrual discomfort. Pondex is applied across domains where additional symptomatic support is needed due to symptoms related to inflammatory or irritative states and systemic imbalance (fever).

Pondex is commonly used to provide symptomatic support for conditions characterized by episodic or fluctuating manifestations, including primary dysmenorrhea (painful periods), osteoarthritis, and rheumatoid arthritis. It helps address symptom clusters that may appear suddenly, such as acute localized pain, joint swelling, and discomfort, providing supportive symptomatic assistance that helps patients cope more steadily during difficult episodes.

“Pondex is relevant for easing symptoms and is often used during phases when symptoms become more noticeable.”

This supportive role may assist with maintaining functional stability and contributes to improved comfort during periods of heightened symptoms. It is used in areas where short-term symptom management is appropriate, especially when pronounced symptoms interfere with daily functioning.


Quick Fact: Relevant for Spasmodic Visceral Pain and Inflammatory Symptoms

Regulatory References

  1. Mefenamic Acid: NIH MedlinePlus overview

Eligibility and Restrictions for Use

Who Can and Cannot Use Pondex?

Eligibility for Pondex (Mefenamic Acid) is defined by official regulatory classifications regarding age, underlying health conditions, and physiological state. The medicine is approved for use in adults and adolescents ge 14 years of age. For pediatric patients under 14 years old, use for standard pain indications is classified as not established. Older adults, who are at a greater risk for adverse events, should use the medicine under conditions of restricted use for the shortest possible duration.

Pondex is contraindicated and must not be used by specific populations. These include patients with known hypersensitivity to mefenamic acid, aspirin, or other NSAIDs. Use is also prohibited for individuals with active gastrointestinal disease (such as ulceration or Inflammatory Bowel Disease), a history of GI bleeding related to previous NSAID use, and those with severe heart, kidney, or liver failure.

Furthermore, Pondex is contraindicated during the third trimester of pregnancy. It is not recommended for women who are nursing or who are actively attempting to conceive, as its use may impair female fertility. Patients with less severe organ impairment or cardiovascular risk factors are required to use the medicine with caution and close monitoring.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information for Pondex identifies several categories of interaction, primarily related to altered systemic exposure and pharmacodynamic risk.

Exposure-Modifying Interactions are classified based on the inhibition or induction of cytochrome P450 (CYP) enzymes, such as CYP3A4, or drug transporters like P-glycoprotein (P-gp). These mechanisms may lead to clinically significant changes in the maximum plasma concentration (Cmax) or the Area Under the Curve (AUC) of Pondex or co-administered drugs.

Pharmacodynamic Risk Interactions are documented for combinations that result in an additive or synergistic effect on specific physiological systems. For example, co-administration with other serotonergic agents may increase the official risk of Serotonin Syndrome.

Specific interacting product classes include pH-dependent medicines (e.g., some antifungals, certain antivirals) and metal cation-containing products (e.g., antacids, iron supplements). Temporal separation is officially required for these cation-containing products to prevent reduced absorption of Pondex.

Interaction Classification Primary Constraint/Mechanism
Contraindicated Combinations Prohibited co-administration due to severe reduction in a co-drug's exposure (e.g., some pH-dependent HIV antivirals).
Clinically Significant Requires INR monitoring (e.g., with Warfarin) or strict clinical surveillance for additive effects (e.g., CNS depression, cardiac effects).

All statements are grounded exclusively in official regulatory product labeling from government health authorities.

Mechanism of Action

How Pondex Works: Mechanism of Action

️ Modulation of the Prostaglandin Synthesis Pathway

This drug's mechanism involves non-selective enzyme inhibition of the COX-1 and COX-2 enzymes, which are critical for converting arachidonic acid into chemical messengers called prostaglandins. This action limits the production of key mediators that drive heightened physiological responses in the periphery, thereby modulating activity within the targeted pathways.


️ Adjustment of Central Thermoregulation

The mechanism engages processes that suppress the synthesis of specific prostaglandins within the hypothalamus, the brain's control center for core temperature. The reduction in the central concentration of these mediators influences the body's temperature set-point, contributing to physiological changes that modulate the body’s temperature regulation.


Attenuation of Peripheral Pain Sensitization

The molecule adjusts activity within peripheral sensory pathways by limiting the local availability of sensitizing mediators at nociceptor nerve endings. This mechanism modulates the signaling of nociceptors, which consequently contributes to modulating the activity of peripheral sensory pathways.

Dosage and Administration Information

How to Use Pondex (Mefenamic Acid)

This section outlines the general principles for the administration and dosing of Mefenamic Acid, the active ingredient in Pondex. The guidance describes standard administration protocols and should not be interpreted as medical advice.


Official Administration Protocol

The medication is designed for oral administration, meaning it is taken by mouth as a capsule or tablet. Standard protocols involve the use of the lowest effective dose for the shortest possible duration to manage acute symptoms.

Usage Instruction Official Guideline Detail
Starting & Maintenance Dose An initial 500 mg loading dose is typically taken once, followed by 250 mg for subsequent maintenance doses.
Timing & Frequency Doses are taken every six hours (q6h) as needed, and should be administered with food or milk to reduce gastrointestinal irritation.
Duration Constraint For acute pain, use is restricted to a maximum of 7 days. For primary dysmenorrhea (painful menstruation), use is typically limited to 2 to 3 days per menstrual cycle.

Procedural Context and Limitations

Administration of Mefenamic Acid for primary dysmenorrhea is intended to begin at the onset of bleeding and associated pain. The dosage regimen is designed to be short-term and is not intended for long-term chronic use. For patients aged 14 years and older, the dosage follows the adult regimen. If a dose is missed, it should not be doubled; the subsequent dose should be taken at the next scheduled time. The strict limits on use duration define the established boundaries for this medication's administration.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Pondex (Mefenamic Acid)


Evidence for Use in Primary Dysmenorrhea (Painful Periods)

Research exploring how symptoms change over time in primary dysmenorrhea (painful periods) has focused primarily on Randomized Controlled Trials (RCTs) and Systematic Reviews. These short-term studies, conducted during periods of increased symptom activity, compared the substance to an inactive substance (placebo) or to other active research agents. The trials monitored patient-reported outcomes describing perceived discomfort and assessed changes in pain severity scores and other outcomes related to physical discomfort.

Findings describe patterns observed in the studies where research tracked changes measured during the study period. Studies report how symptoms evolved in the observed populations, and this evidence exists within the broader evidence landscape for the substance's use in this condition.

However, follow-up durations were limited in these core efficacy trials. Long-term effects are not fully established; there is limited information for long-term outcomes detailing the use of this drug repeatedly across many years.


Evidence for Use in Mild to Moderate Acute Pain

Pondex was studied in research exploring mild to moderate acute pain, often in research contexts involving fluctuating or unstable symptoms, such as post-operative dental pain. The research structure relied heavily on single-dose, short-term RCTs which monitored outcomes related to physical discomfort over defined, short time intervals, frequently limited to just a few hours post-administration.

Research tracked changes measured during the study period, particularly with respect to time until a reported change in symptoms and overall pain intensity scores. These findings describe patterns observed in the studies that were usually conducted during periods of increased symptom activity. Studies monitored how symptom patterns evolved between the active substance and the inactive control in these short-term models.


Research Gaps and Uncertainties

While robust for short-term pain relief, the evidence landscape has several areas where certainty remains low. Comparative evidence is lacking in some areas, meaning direct comparison trials with all newer analgesics are not fully established across all indications. The sample sizes were modest in some of the older trials for chronic conditions. Research provides context about what has been observed so far, but evidence highlights what is known and what is still uncertain about the drug's long-term profile.

Key Studies & References

  1. Mefenamic Acid Monograph
  2. Mefenamic Acid: NIH MedlinePlus overview

Frequently Asked Questions (FAQ)

Common questions about Pondex (FAQ)


Q: How quickly should I expect Pondex to start working?

A: Studies on the drug’s active ingredient show that it is rapidly absorbed into the bloodstream. The medication typically reaches its peak concentration within approximately two to four hours after being taken by mouth. This peak level is generally associated with the drug's maximum effect.

Q: Is Pondex safe for older adults to use?

A: Official labeling notes that older adults face a greater risk for serious gastrointestinal side effects compared to younger patients. Regulatory documents indicate that use in this population is advised only under conditions of restricted use, emphasizing the importance of the lowest effective amount for the shortest duration.

Q: What is the longest time period people usually take Pondex for?

A: The medication is primarily intended for short-term use. For acute pain conditions, use is strictly limited by regulatory guidelines to a maximum of 7 days. When used for painful menstruation, the duration is typically restricted to 2 to 3 days per menstrual cycle.

Q: Has there been a lot of research done on the effectiveness of Pondex?

A: The drug's efficacy for its approved indications is supported by evidence derived from Randomized Controlled Trials (RCTs). These studies provide the basis for the regulatory approval of the medication for the short-term relief of acute pain and painful menstruation.

Q: Is Pondex suitable for long-term use?

A: No, this medication is not intended for long-term chronic use. Official warnings indicate that the risk of serious adverse events, particularly those affecting the cardiovascular and gastrointestinal systems, may increase with prolonged duration of use.

Q: Why are some people not supposed to take Pondex?

A: The drug is contraindicated (must not be used) for specific patient populations, including those with certain heart, liver, or kidney failures, or active gastrointestinal disease. This is due to the potential for serious adverse events outlined in the official product labeling.

Q: Are there any serious, but less common, side effects of Pondex?

A: Yes, official warnings highlight the risk of serious, potentially fatal side effects, which include cardiovascular thrombotic events (like heart attack or stroke), gastrointestinal bleeding or ulcers, and severe skin reactions. Official patient information often describes the signs of these serious events.

Q: Can taking Pondex cause stomach issues or nausea?

A: Yes, common side effects documented in official labeling include gastrointestinal symptoms like diarrhea, abdominal pain, vomiting, and nausea. Official labeling notes that in cases of persistent or severe diarrhea, stopping the medication may be considered by a healthcare professional.

Q: What happens if Pondex is taken with antacids?

A: Taking this medication with certain antacids, specifically those containing magnesium hydroxide, can increase the rate and total amount of the drug absorbed into the body. This interaction may lead to increased absorption of the medication, which can raise the potential for side effects.

Q: Can Pondex be taken with over-the-counter pain relievers?

A: Official warnings advise against co-administering this drug with other Nonsteroidal Anti-inflammatory Drugs (NSAIDs), as this combination is associated with an increased risk of serious adverse events, particularly gastrointestinal bleeding.

Q: What happens if I forget to take a dose of Pondex?

A: Regulatory instructions state that if a dose is missed, it can be taken as soon as the patient remembers. However, if it is nearly time for the next scheduled dose, the missed one should be skipped. It is important never to take a double dose.

Q: Are there any specific foods or drinks I need to avoid while on Pondex?

A: Official warnings note that consuming alcohol while taking this medication is associated with an increased risk of serious stomach bleeding. The drug is also advised to be taken with food or milk to minimize stomach irritation.

Q: Is it normal to feel a bit dizzy after starting Pondex?

A: Yes, dizziness is listed as a possible side effect in the official product information. Patients who experience dizziness or other nervous system effects may need to exercise caution when driving or operating machinery, as noted in official patient information.

Q: Does Pondex affect my sleep patterns?

A: The official lists of potential side effects include central nervous system effects such as insomnia (difficulty sleeping) and somnolence (drowsiness). These effects are typically less common but have been reported with the use of this medication.

Q: How long does Pondex stay in your system after you stop taking it?

A: The drug’s active ingredient has a relatively short elimination half-life, which is approximately two hours. The majority of the drug and its breakdown products are then cleared from the body through the urine and feces.

Q: Does Pondex interact with common supplements like multivitamins?

A: Official regulatory documents specifically address products that contain metal cations, such as iron supplements. To help prevent reduced absorption of the active ingredient, official guidance requires a temporal separation when taking this medication with metal cation-containing products.

Q: Does Pondex cause weight gain or weight loss?

A: Unexplained weight gain is mentioned in the official safety information as a potential sign of a serious adverse event that should be promptly reported to a healthcare provider. General 'weight changes' are also listed as a potential side effect.

Q: How does Pondex interact with birth control pills?

A: This medication may interact with specific types of oral contraceptives, such as those containing drospirenone, and may be associated with an increased risk of elevated potassium levels in certain patients. NSAIDs may also affect ovulation in females of reproductive potential.

Q: Will taking Pondex make me tired during the day?

A: Official adverse reaction lists include somnolence (drowsiness) and excessive tiredness as potential side effects. If drowsiness occurs, patients may need to use caution when performing activities that require concentration or physical coordination.

Q: Is it okay to drive or operate machinery while taking Pondex?

A: Official patient information notes that caution may be required when engaging in activities that require mental alertness, such as driving or operating machinery, due to the potential for side effects like dizziness or drowsiness.

Q: Is Pondex available as a generic medication?

A: Yes, the active ingredient in this medication, mefenamic acid, is widely available in many markets as a generic drug.

Q: Does Pondex have any impact on mental clarity or focus?

A: Official adverse reaction lists include central nervous system effects such as confusion, anxiety, depression, and nervousness. Patients who notice changes in their mental state should report these to a healthcare provider.

Q: Is Pondex a prescription-only drug?

A: Yes, this medication is designated as 'Rx only' in the United States and similar markets, meaning it is only available with a valid prescription from a licensed healthcare provider.

Q: Does Pondex have a risk of dependence or addiction?

A: The medication is a Nonsteroidal Anti-inflammatory Drug (NSAID). Official regulatory labeling for this class of drugs does not list the drug as a controlled substance and does not typically indicate a risk of physical dependence or addiction.

Q: How is Pondex eliminated from the body?

A: The drug and its resulting metabolites are processed and removed from the body primarily via excretion. Regulatory data indicates that a majority of the substance is eliminated through the urine and a portion is excreted in the feces.

Q: Are allergic reactions to Pondex common?

A: While the drug is contraindicated for those with a known allergy to it, severe allergic reactions (anaphylaxis) are rare but serious. Official warnings note that if signs of a severe allergic reaction occur, such as difficulty breathing or swelling, emergency medical attention is required.

Q: What should I do if the side effects from Pondex are bothering me?

A: Official product information suggests that any severe symptoms or side effects that are bothersome or persistent should be reported to a healthcare professional. For example, severe diarrhea may lead to a recommendation to stop the medication.

Q: Can Pondex be crushed or split if it's a tablet?

A: Unless the official prescribing information states that the tablet is scored and approved for splitting, it is generally recommended to swallow it whole.

Q: Are there any known interactions between Pondex and herbal remedies?

A: Official regulatory documents generally advise patients to inform their healthcare provider about all herbal products and supplements being used, as potential interactions may exist.

How should Pondex be stored and disposed of?

How to Store and Dispose of Pondex?

Storage and Protection Requirements

Pondex must be stored according to manufacturer instructions, typically in a cool, dry place. Medication must be protected from heat, light, and moisture to maintain stability and effectiveness. Always keep Pondex in its original container with the label intact. The medicine must be secured in a locked cabinet or drawer, entirely out of the reach and sight of children, pets, and guests, to prevent accidental ingestion.

Official Disposal Procedures

The primary method for disposing of unused or expired Pondex is through drug take-back programs or mail-back envelopes. If these options are unavailable and the medicine is not on the regulatory “flush list,” do not flush it down a sink or toilet. Instead, remove the medicine from its original container, mix it with an unappealing substance like used coffee grounds or cat litter, place the mixture into a sealed plastic bag or container, and dispose of it in the household trash. Scratch out all personal information on the empty packaging before disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Pondex found in:

A-Z Index: